Osaic Holdings
MGX icon

Osaic Holdings’s Metagenomi Therapeutics MGX Stock Holding History

Osaic Holdings’s Portfolio MGX Stock Details MGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25K Sell
1,891
-1,000
-35% -$1.34K ﹤0.01% 7244
2026
Q1 		$3.87K Hold
2,891
– – ﹤0.01% 6805
2025
Q4 		$4.68K Sell
2,891
-250
-8% -$541 ﹤0.01% 6743
2025
Q3 		$6.29K Sell
3,141
-44
-1% -$89 ﹤0.01% 6623
2025
Q2 		$4.71K Buy
3,185
+44
+1% +$69 ﹤0.01% 6570
2025
Q1 		$4.27K Buy
3,141
+1,672
+114% +$3.98K ﹤0.01% 6264
2024
Q4 		$5.3K Hold
1,469
– – ﹤0.01% 6158
2024
Q3 		$3.19K Buy
+1,469
New +$5.1K ﹤0.01% 6409

Other funds holding MGX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings's MGX Position: Q2 2026 in Review

Osaic Holdings reduced its Metagenomi Therapeutics (MGX) stake by 35% in Q2 2026, selling an estimated $1.34K and leaving 1,891 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #7244.

Osaic Holdings first reported a position in MGX in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.29K in Q3 2025. 43 funds tracked by Wall St. Rank hold MGX as of Q2 2026.

  • Osaic Holdings held 1,891 shares of Metagenomi Therapeutics worth $2.25K as of Q2 2026.
  • Osaic Holdings sold 1,000 Metagenomi Therapeutics shares in Q2 2026, an estimated $1.34K.
  • Metagenomi Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7244 holding.
  • Osaic Holdings first reported a position in Metagenomi Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Metagenomi Therapeutics position peaked at $6.29K in Q3 2025.
  • 43 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.